Ingevity Corporation (NYSE:NGVT) Receives Average Recommendation of “Hold” from Brokerages

Ingevity Corporation (NYSE:NGVT) has received an average recommendation of “Hold” from the five research firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $80.00.

NGVT has been the subject of several research analyst reports. BMO Capital Markets reiterated an “outperform” rating and set a $83.00 target price on shares of Ingevity in a research note on Monday, March 2nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Wells Fargo & Company boosted their price target on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Jefferies Financial Group reissued a “buy” rating and issued a $82.00 price target on shares of Ingevity in a report on Thursday, February 26th. Finally, Wall Street Zen raised shares of Ingevity from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th.

Insider Transactions at Ingevity

In other Ingevity news, SVP Terrance M. Dyer sold 496 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president owned 7,202 shares of the company’s stock, valued at $493,264.98. The trade was a 6.44% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.88% of the stock is owned by company insiders.

Institutional Investors Weigh In On Ingevity

Several institutional investors and hedge funds have recently bought and sold shares of NGVT. Principal Financial Group Inc. increased its holdings in Ingevity by 269.9% in the 4th quarter. Principal Financial Group Inc. now owns 652,237 shares of the company’s stock valued at $38,599,000 after buying an additional 475,907 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Ingevity by 311.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock valued at $23,769,000 after buying an additional 454,579 shares during the period. Simcoe Capital Management LLC increased its holdings in Ingevity by 188.8% in the 2nd quarter. Simcoe Capital Management LLC now owns 624,935 shares of the company’s stock valued at $26,928,000 after buying an additional 408,508 shares during the period. Boston Partners increased its holdings in Ingevity by 141.6% in the 4th quarter. Boston Partners now owns 620,360 shares of the company’s stock valued at $36,719,000 after buying an additional 363,584 shares during the period. Finally, Bessemer Group Inc. increased its holdings in Ingevity by 465.9% in the 1st quarter. Bessemer Group Inc. now owns 314,739 shares of the company’s stock valued at $22,419,000 after buying an additional 259,124 shares during the period. Institutional investors own 91.59% of the company’s stock.

Ingevity Stock Performance

NYSE:NGVT opened at $65.96 on Friday. The firm has a market capitalization of $2.29 billion, a PE ratio of -18.58 and a beta of 1.18. Ingevity has a 1 year low of $39.74 and a 1 year high of $79.29. The firm’s fifty day simple moving average is $71.55 and its 200 day simple moving average is $66.34. The company has a current ratio of 1.42, a quick ratio of 0.92 and a debt-to-equity ratio of 27.83.

Ingevity (NYSE:NGVT) last released its earnings results on Wednesday, May 6th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $0.84 by $0.31. The firm had revenue of $258.00 million during the quarter, compared to analysts’ expectations of $254.73 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. The business’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same period in the prior year, the company earned $1.01 EPS. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, sell-side analysts anticipate that Ingevity will post 5.05 EPS for the current year.

About Ingevity

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.